Search results
Bryhali dosage: Form, strength, how to use, and more
Medical News Today· 4 days agoBryhali (halobetasol) is a brand-name drug prescribed to treat plaque psoriasis in adults. Bryhali belongs to a drug class called corticosteroids. Note:...
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena via Yahoo Finance· 6 days agoLEO Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 6 days agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 7 days agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 7 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 7 days agoIf the Phase Ia segment is successful, VYNE will advance the drug to Phase Ib trials in individuals...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace via Yahoo Finance· 7 days agoAmid a challenging market environment, one of your best bets could be to target biotech stocks to...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 2 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 6 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...